Coulter Corp., of Miami, received an approvable letter from theFDA for a blood screening product, the Coulter HIV-1 p24 AntigenAssay, that detects the presence of the p24 antigen of HIV. Theproduct is intended for use by blood and plasma collection centers toscreen for HIV.

Geron Corp., of Menlo Park, Calif., and Dianon Systems Inc., ofStratford, Conn., entered into a technology development agreement toexplore telomerase detection as a cancer diagnostic technology.Telomerase is an enzyme found in cancers but inactive in nearly allnormal cells. Terms were not disclosed.

(c) 1997 American Health Consultants. All rights reserved.